TREM2 and myeloid sarcoma: Indeed, the experimental autoimmune encephalomyelitis (EAE) mouse model of MS injected with anti-TREM2 monoclonal antibody (mAb) showed a reduced clearance of myelin and exacerbation in the disease severity [113].